[1] It represents a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, distinguishing it from GLP-1-only medications like semaglutide
Costill, DL.(1994) Fink, WJ
Simpson EP, Henry YK, Henkel JS, Smith RG, Appel SH
Many people are reluctant to stop using GLP-1 and give up the weight loss gains theyve made if it means having to deal with ongoing hair loss issues
Current Delivery Methods: Injectable, Oral, and Compounded Options Three delivery pathways currently dominate GLP-1 therapy: subcutaneous injectables (weekly or daily), oral tablets, and compounded formulations through licensed 503A pharmacies
Want Best Available Medication: Tirzepatide currently produces the best weight loss results of any medication available